Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-02

FDA Approved: LUBIPROSTONE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' original generic application for lubiprostone to treat chronic idiopathic constipation, opioid-induced constipation, and ir…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LUBIPROSTONE (lubiprostone)

Snippet

ORIG AP for LUBIPROSTONE (LUBIPROSTONE)